Living with inflammatory bowel disease (IBD) means managing a condition in which the immune system, reacting to the gut and its bacteria, drives ongoing inflammation in the bowel. IBD is best described as immune-mediated rather than a classic autoimmune disease, but people with IBD do have a higher chance of experiencing other immune-related conditions, either affecting the gut’s “neighbouring” systems or as separate diagnoses. Understanding this may help you feel more prepared when discussing your health with your medical team.
What is an immune-mediated condition?
In an immune-mediated condition, the immune system, which normally protects the body from infection, becomes overactive and drives inflammation in the body’s own tissues. In IBD this affects the gut. In other immune-mediated conditions it affects different parts of the body, such as the joints, skin, or thyroid gland. These are separate diagnoses, but they can share underlying features with IBD.
Why people with IBD may develop other immune-mediated conditions
The reasons are not fully understood, but several factors contribute.
Shared immune patterns.
If the immune system is already prone to overreacting in one place, it may be more likely to do so elsewhere. People with one immune-mediated condition often share inherited traits that make another more likely.
Genetic overlap.
Research shows that some of the same genes linked to IBD are also linked to other immune-mediated conditions, most notably psoriasis and ankylosing spondylitis. These genes influence how the immune system manages inflammation and recognises the body’s own tissue. Having these variants raises the likelihood of another condition but does not make it certain.
Ongoing inflammation.
Long-term immune activity in the gut may influence the immune system more widely, which may make some people more prone to inflammation elsewhere.
Environmental factors.
Infections, stress, smoking, and changes in gut bacteria may all influence the immune system, particularly in someone who already has a genetic predisposition.
Conditions that occur more often in people with IBD
Large population studies show that several separate immune-mediated conditions are diagnosed more often in people with IBD than in the general population. The increase in risk is usually modest, and most people with IBD never develop any of them, but awareness helps with earlier recognition. They include:
- Autoimmune thyroid disease, such as Hashimoto’s thyroiditis and Graves’ disease, which can affect energy, weight, and mood.
- Psoriasis, an immune-mediated skin condition.
- Coeliac disease, an immune reaction to gluten.
- Type 1 diabetes, in which the immune system affects insulin-producing cells.
- Rheumatoid arthritis and ankylosing spondylitis, immune-mediated forms of joint and spinal inflammation.
What this means for monitoring and care
If you have IBD, your team may look out for signs of these conditions, particularly if you develop new symptoms. It helps to report anything new or unusual even if it seems unrelated to your gut, such as changes in energy, weight or mood, joint pain, or skin changes. Keeping a simple record of symptoms over time can make patterns easier to spot and discuss. Testing is usually guided by symptoms rather than done for everything at once, and early detection can help prevent complications.
Practical takeaways
- People with IBD have a somewhat higher change of some other immune-mediated conditions, but most people will not develop them.
- These are separate diagnoses that share immune and genetic features with IBD.
- Report new symptoms such as changes in energy or mood, joint pain, or skin changes to your team.
- Monitoring is usually guided by symptoms; ask your team what is relevant for you.
- Treatment of the IBD itself remains the priority, and regular contact with your team supports long-term stability.
Conclusion
People with IBD may be more likely to develop certain other immune-mediated conditions because of shared genetic, immune, and environmental factors. This does not happen to everyone, but being aware of the link and reporting new symptoms can help you and your team manage your health effectively.
References
- Halling ML, Kjeldsen J, Knudsen T, Nielsen J, Hansen LK. Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases. World J Gastroenterol. 2017;23(33):6137-6146.
- Monteleone G, Moscardelli A, Colella A, Marafini I, Salvatori S. Immune-mediated inflammatory diseases: common and different pathogenic and clinical features. Autoimmun Rev. 2023;22(10):103410.
- Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491(7422):119-124.
- Ellinghaus D, Jostins L, Spain SL, et al. Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. Nat Genet. 2016;48(5):510-518.
This article is intended for informational and educational purposes only. It does not constitute medical advice and should not be used as a substitute for professional medical guidance, diagnosis, or treatment.